Shaomeng Wang

Also affiliated with Michigan Medicine, Michigan Center for Translational Pathology, University of Colorado Cancer Center, U-M Rogel Cancer Center, University of Colorado Denver

Biochemistry, Genetics and Molecular BiologyArts and HumanitiesMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment”.

Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment

Neoplasia(2020)10.1016/j.neo.2019.12.003

N/A

4.3DataRank · unranked

142 citations

Chao Wang, Xin Han, Lanbo Xiao, Ester Fernández‐Salas, Pushpinder Bawa +8 more

Targeting Mll1 H3K4 methyltransferase activity to guide cardiac lineage specific reprogramming of fibroblasts

UNC Libraries(2020)10.17615/hmmq-gf75

N/A

0DataRank · unranked

0 citations

Zhong Wang, Liu Liu, Li Wang, Leonid Gnatovskiy, Ienglam Lei +5 more

Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00900

N/A

0DataRank · unranked

142 citations

Lijie Zhao, Xin Han, Chong Qin, Bukeyan Miao, Donna McEachern +10 more

Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer

Journal of Medicinal Chemistry(2021)10.1021/acs.jmedchem.1c00882

N/A

0DataRank · unranked

139 citations

Lijie Zhao, Weiguo Xiang, Chong Qin, Bukeyan Miao, Donna McEachern +8 more

The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunity

Nature Immunology(2021)10.1038/s41590-021-00888-3

N/A

0DataRank · unranked

105 citations

Ilona Kryczek, Shasha Li, Li Xiong, Angelo Aguilar, Shuang Wei +15 more

Multi-dimensional analyses identify genes of high priority for pancreatic cancer research

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.28.446056

N/A

0DataRank · unranked

1 citations

Heather Giza, Maya Nassif, Verodia Charlestin, Rosa E. Menjivar, Daeho Kim +8 more

Biliary NIK promotes ductular reaction and liver injury and fibrosis in mice

Nature Communications(2022)10.1038/s41467-022-32575-8

N/A

0DataRank · unranked

48 citations

Xiao Yan Zhong, Hong Shen, Liang Sheng, Suthat Liangpunsakul, Anna S. Lok +4 more

Therapeutic Strategies to Activate p53

Pharmaceuticals(2022)10.3390/ph16010024

N/A

0DataRank · unranked

25 citations

Shaomeng Wang, Angelo Aguilar

Targeting the Estrogen Receptor for the Treatment of Breast Cancer: Recent Advances and Challenges

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00136

N/A

0DataRank · unranked

96 citations

J. Thomas, Ranjan Kumar Acharyya, James M. Rae, Shaomeng Wang, Rohan Kalyan Rej

Discovery of ARD-2051 as a Potent and Orally Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00405

N/A

0DataRank · unranked

58 citations

Lijie Zhao, Weiguo Xiang, Bukeyan Miao, Chong Qin, Mi Wang +16 more

IL-13–induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.07.021

N/A

0DataRank · unranked

34 citations

Ankit Sharma, Varsha Ganesan, Daysha Ferrer-Torres, James Krempski, Gila Idelman +13 more

Precise Conformational Control Yielding Highly Potent and Exceptionally Selective BRD4 Degraders with Strong Antitumor Activity

Journal of Medicinal Chemistry(2023)10.1021/acs.jmedchem.3c00520

N/A

0DataRank · unranked

27 citations

Biao Hu, Fuming Xu, Mi Wang, Chong Qin, Donna McEachern +3 more

Loss of LCMT1 and biased protein phosphatase 2A heterotrimerization drive prostate cancer progression and therapy resistance

Nature Communications(2023)10.1038/s41467-023-40760-6

N/A

0DataRank · unranked

17 citations

Caitlin M. O’Connor, Chandan Kanta Das, Mohammed Alhusayan, Brijesh Kumar Verma, Sehbanul Islam +26 more

Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance

Cancer Cell(2024)10.1016/j.ccell.2024.10.010

N/A

0DataRank · unranked

87 citations

Kole Tison, Yuheng Du, Paul D. Kirchhoff, Chan Kim, Weichao Wang +20 more

Progestogen-driven B7-H4 contributes to onco-fetal immune tolerance

Cell(2024)10.1016/j.cell.2024.06.012

N/A

0DataRank · unranked

55 citations

Yijian Yan, Shasha Li, Ying Xu, Abhijit Parolia, Syed Rizvi +27 more

Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01946

N/A

0DataRank · unranked

24 citations

Haibin Zhou, Longchuan Bai, Donna McEachern, Dimin Wu, Ranjan Kumar Acharyya +12 more

Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer

Journal of Medicinal Chemistry(2024)10.1021/acs.jmedchem.4c01521

N/A

0DataRank · unranked

21 citations

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, Dimin Wu, Jianfeng Lü +18 more

Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancers

Journal of Clinical Investigation(2024)10.1172/jci177142

N/A

0DataRank · unranked

14 citations

Yunpeng Bai, Jinmin Miao, Allison A. Murray, Jianping Lin, Jiajun Dong +8 more

IL-4–STAT6 axis amplifies histamine-induced vascular endothelial dysfunction and hypovolemic shock

Journal of Allergy and Clinical Immunology(2024)10.1016/j.jaci.2024.05.009

N/A

0DataRank · unranked

11 citations

Amnah Yamani, Lakshmi Narasimha Thota, Sahiti Marella, Varsha Ganesan, Ankit Sharma +8 more

SHP2 ablation mitigates osteoarthritic cartilage degeneration by promoting chondrocyte anabolism through SOX9

The FASEB Journal(2024)10.1096/fj.202400642r

N/A

0DataRank · unranked

6 citations

Huiliang Yang, Changwei Wang, Mingliang Wang, Jiahui Huang, Thedoe Nyunt +8 more

p300/CBP degradation is required to disable the active AR enhanceosome in prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.29.587346

N/A

0DataRank · unranked

11 citations

Zhixiang Chen, Yuanyuan Qiao, Jean Ching-Yi Tien, Eleanor Young, Rahul Mannan +19 more

Proteolysis-targeting vaccines (PROTAVs) for robust combination immunotherapy of melanoma

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.10.01.616069

N/A

0DataRank · unranked

0 citations

Ting Su, Furong Cheng, Shurong Zhou, Xiang Liu, Mi Wang +15 more

Development of PVTX-405 as a potent and highly selective molecular glue degrader of IKZF2 for cancer immunotherapy

Nature Communications(2025)10.1038/s41467-025-58431-z

N/A

0DataRank · unranked

19 citations

Harshil Dhruv, Xuqing Zhang, Rohan Kalyan Rej, Longchuan Bai, Donna McEachern +14 more

Targeting histone H2B acetylated enhanceosomes via p300/CBP degradation in prostate cancer

Nature Genetics(2025)10.1038/s41588-025-02336-6

N/A

0DataRank · unranked

19 citations

Zhixiang Chen, Yuanyuan Qiao, Jean C. Tien, Eleanor Young, Rahul Mannan +24 more

Multidimensional analyses identify genes of high priority for pancreatic cancer research

JCI Insight(2025)10.1172/jci.insight.174264

N/A

0DataRank · unranked

6 citations

Heather M. Giza, Maya Nassif, Verodia Charlestin, Rosa E. Menjivar, Dae-Ho Kim +13 more

Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance 2251

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.189

N/A

0DataRank · unranked

1 citations

Kole Tison, Yuheng Du, Paul D. Kirchhoff, Chan Kim, Weichao Wang +20 more

PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models

Neurotherapeutics(2025)10.1016/j.neurot.2025.e00732

N/A

0DataRank · unranked

2 citations

Satya Reddy, Curtis J. Kuo, Weiguo Xiang, Diane E. Merry, Christopher Grunseich +3 more

Correction to “Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer”

Journal of Medicinal Chemistry(2025)10.1021/acs.jmedchem.5c00592

N/A

0DataRank · unranked

1 citations

Rohan Kalyan Rej, Biao Hu, Zhixiang Chen, Dimin Wu, Jianfeng Lü +18 more

Activity of PROTAC MDM2 Degrader in Primary Leukemia Cells and PDX models

Research Square(2025)10.21203/rs.3.rs-7982024/v1

N/A

0DataRank · unranked

0 citations

Malathi Kandarpa, Luke F. Peterson, Harish Potu, Megha Ramappan, Yi‐Hong Liu +3 more

Balance between STAT5 and STAT3 determines dendritic cell function and tumor immunity 2337

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.264

N/A

0DataRank · unranked

0 citations

Kole Tison, Haibin Zhou, Longchuan Bai, Ranjan Kumar Acharyya, Donna McEachern +22 more